Page last updated: 2024-10-30

mesalamine and Bone Marrow Diseases

mesalamine has been researched along with Bone Marrow Diseases in 1 studies

Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.

Bone Marrow Diseases: Diseases involving the BONE MARROW.

Research Excerpts

ExcerptRelevanceReference
"6-Mercaptopurine (6-MP) is an effective maintenance medication in patients with ulcerative colitis (UC), but toxic effects like myelosuppression limit its clinical benefit."2.75Thiopurine maintenance therapy for ulcerative colitis: the clinical significance of monitoring 6-thioguanine nucleotide. ( Abe, J; Arai, O; Hanai, H; Hosoda, Y; Iida, T; Ikeya, K; Kageoka, M; Kubota, T; Maruyama, Y; Miwa, I; Oohata, A; Takeuchi, K; Watanabe, F; Yoshirou, S, 2010)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hanai, H1
Iida, T1
Takeuchi, K1
Arai, O1
Watanabe, F1
Abe, J1
Maruyama, Y1
Oohata, A1
Ikeya, K1
Kageoka, M1
Miwa, I1
Yoshirou, S1
Hosoda, Y1
Kubota, T1

Trials

1 trial available for mesalamine and Bone Marrow Diseases

ArticleYear
Thiopurine maintenance therapy for ulcerative colitis: the clinical significance of monitoring 6-thioguanine nucleotide.
    Inflammatory bowel diseases, 2010, Volume: 16, Issue:8

    Topics: Adolescent; Adult; Aged; Bone Marrow; Bone Marrow Diseases; Colitis, Ulcerative; Drug Monitoring; Er

2010